Immuno-Oncology Symposium - Part 1
Immuno-Oncology Symposium held on November 11, 2023 which covers the latest advancements in Immuno-Oncology and its optimal clinical application. Part 1 covers, the Opening talk entitled "Cancer Immunology Primer" by Kim Margolin, MD Saint John's Cancer Institute, followed by Panel discussion of Immunotherapy Management Challenges with Anna Wu, PhD, City of Hope, Allison Betof Warner, MD, PhD, Stanford, Katy Tsai, MD, UCSF and Gregory Daniels, MD, UC San Diego.

▶︎
Immuno-Oncology Symposium Part 2

▶︎
Immuno-oncology: Cold to Hot Tumours

▶︎
Deep Insight Into Immuno-Oncology: Immunotherapy Pathways, Targets, and Biomarkers

▶︎
Stem Cells and Next Generation Regenerative Medicine Therapies

▶︎
"The mechanistic basis of cancer immunotherapy" | 30 October 2024

▶︎
Immuno-Oncology Symposium - Part 4

▶︎
PD-L1/PD-1 Cancer Immunotherapy and New Targets - Gordon Freeman, PhD

▶︎
Learn the Basics of Immunotherapy from David Reardon, M.D.

▶︎
Chronic Cancer Tests: Chronic Lymphocytic Leukemia | The Patient Story

▶︎
"Immune evasion of stem cells and cancer stem cells" by Dr. Judith Agudo

▶︎
The Future of Cancer Immunotherapy with Dr. James Allison

▶︎
Immune Checkpoint Blockade in Cancer Therapy

▶︎
The Latest in Immunotherapy to Treat Cancer

▶︎
Deciphering Immuno-oncology: Targeting Innate Immunity in Cancer

▶︎
Immunotherapy and Side Effects

▶︎
Antineoplastic Agents | Clinical Medicine

▶︎
Stanford Cancer Institute Breakthroughs in Cancer: Jennifer Wargo, MD, MMSc

▶︎
Aspirin and cancer: the emerging evidence

▶︎
177 - The development of cancer immunotherapy and its promise for treating advanced cancers

▶︎
